We are live on ! Find out more
PVMCI

Polaris Venture Management Co IV Portfolio holdings

AUM $62.4M
1-Year Est. Return 33.04%
This Fund
S&P 500
This Quarter Est. Return
+69.79%
1 Year Est. Return
+33.04%
3 Year Est. Return
+52.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
–
Cap. Flow
+$93.7M
Cap. Flow %
62.27%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$75.6M
2
TTGT icon
TechTarget
TTGT
+$9.56M
3
ALIM
Alimera Sciences
ALIM
+$8.55M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 92.26%
2 Technology 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
1
DELISTED
Acceleron Pharma
XLRN
$124M 82.43%
+3,133,234
New +$75.6M
ALIM
2
DELISTED
Alimera Sciences
ALIM
$14.8M 9.83%
+209,890
New +$8.55M
TTGT icon
3
TechTarget
TTGT
$325M
$11.7M 7.74%
+1,699,406
New +$9.56M

Similar funds

HCM
Hayman Capital Management Dallas, Texas $63.3M AUM 3.78% 1-Year Est. Return
LVP
Limestone Value Partners Houston, Texas $64M AUM 4.56% 1-Year Est. Return
SVP
Springbank Value Partners Hampton Bays, New York $65.5M AUM 35.56% 1-Year Est. Return
HWM
Heartwood Wealth Management London, United Kingdom $58.9M AUM 14.96% 1-Year Est. Return
CCG
Crescent Capital Group Los Angeles, California $56.8M AUM 11.67% 1-Year Est. Return
CSM
Central Square Management Naperville, Illinois $56.6M AUM 27.75% 1-Year Est. Return
KCP
Keane Capital Partners Charlotte, North Carolina $56M AUM
EL
Elberon LLC Austin, Texas $56M AUM 14.07% 1-Year Est. Return

Polaris Venture Management Co IV's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Polaris Venture Management Co IV, which disclosed 3 positions worth $151M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Acceleron Pharma: 3,133,234 shares worth $124M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, followed by Technology.

  • Polaris Venture Management Co IV's largest Q4 2013 buy was Acceleron Pharma: 3,133,234 shares worth $124M.
  • Polaris Venture Management Co IV's ten largest holdings make up 100% of its $151M portfolio in Q4 2013.
  • Polaris Venture Management Co IV disclosed 3 positions in Q4 2013, its first 13F filing on record.

Based on Polaris Venture Management Co IV's 13F filing for Q4 2013, filed 14 Feb 2014.